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Objective: Illness management and recovery (IMR) is an evidence-based, manualized 
illness self-management program for people with severe mental illness. This study sought 
to develop a measure of IMR clinician competence and test its reliability and validity. 
Methods: Two groups of subject matter experts each independently created a clinician-
level IMR competence scale based on the IMR Fidelity Scale and on two unpublished 
instruments used to evaluate provider competence. The two versions were merged, and 
investigators used the initial version to independently rate recordings of IMR sessions. 
Ratings were compared and discussed, discrepancies were resolved, and the scale was 
revised through 14 iterations. The resulting IMR Treatment Integrity Scale (IT-IS) 
includes 13 required items and three optional items rated only when the particular skill is 
attempted. Four independent raters then used the IT-IS to score tapes of 60 IMR sessions 
and 20 control group sessions. Results: The IT-IS showed excellent interrater reliability. 
A factor analysis supported a one-factor model that showed good internal consistency. 
The scale successfully differentiated between IMR and control groups. Reliability and 
validity of individual items varied widely. Conclusions: The IT-IS is a promising 
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measure of clinician competence in providing IMR. The scale could be used for research 
and quality assurance and as a supervisory feedback tool. Future research is needed to 
examine item-level changes, predictive validity of the IT-IS, discriminant validity 
compared with other more structured interventions, and the reliability and validity of the 
scale for nongroup IMR. (Psychiatric Services 63:XXXXXXXX, 2012; doi: 
10.1176/appi.ps.201100144)  
 
Measures of treatment integrity are crucial in determining adherence to a specific 
program model and differentiating a practice from others (1–4). Treatment integrity is 
equally important to clinical research and dissemination of evidence-based practices. 
Accurate dissemination requires specification of the critical components of a given model 
(5), development of operational definitions of the critical ingredients (6), and 
development of standardized assessments of the degree of implementation (7). In addition 
to assisting with dissemination, adherence to program models has been shown to be a 
predictor of consumer outcomes (7,8). The identification of evidence-based practices, 
together with the need for broad and accurate dissemination of such practices, has led to a 
general call for the development of methods to empirically validate adherence to program 
models (9–13). However, treatment integrity is often neglected in both research and 
practice (1,14–16).  
 
The illness management and recovery (IMR) program is an evidence-based approach to 
teaching consumers with severe mental illness strategies for setting and achieving 
personal recovery goals and acquiring the knowledge and skills to manage their illnesses 
(17,18). IMR was developed as part of the National Implementing Evidence-Based 
Practices Project of the Substance Abuse and Mental Health Services Administration (19) 
and includes an implementation toolkit with a workbook, practice demonstration videos, 
brochures, and consumer handouts (20). IMR prescribes the use of complex clinical 
techniques to support consumers in learning the curriculum, setting and achieving goals, 
and managing their illness. Interventions include cognitive-behavioral techniques (21,22), 
motivation-based strategies (23), and interactive educational techniques. IMR’s 
effectiveness has been supported by longitudinal (24,25), multisite (26–28), and 
randomized controlled trials (29–31). Collectively, these studies have shown positive 
treatment outcomes, with increased illness self-management and coping skills and 
reduced hospitalization rates (26).  
 
IMR, as with all the programs in the National Implementing Evidence-Based Practices 
Project (32), utilizes a program-level fidelity scale. The IMR Fidelity Scale (33) is a 13-
item scale to assess the degree of implementation of the entire program rather than of an 
individual practitioner. Each item is rated on a 5-point, behaviorally anchored scale. This 
scale has been used in state implementation projects (26,28). The sensitivity of the scale 
has been demonstrated by increased scores after training and consultation (32). This type 
of program-level scale adopts a broad view of how services are provided by focusing 
primarily on structural aspects of the program (for example, size of the intervention 
group) or clinician skills in the aggregate.  
 
3 
 
Although program-level fidelity is important, integrity is a multipart construct including 
adherence, competence, and differentiation (16). Therapist competence—“level of skill 
shown by the therapist in delivering the treatment” (34)—may be more appropriate for 
programs requiring specific, nuanced clinical interventions. For instance, practitioners 
must understand the program model and have the skills to implement it (8,35,36). 
Moreover, treatment integrity measures that assess actual use of knowledge and skills are 
crucial and are an advancement over assessment techniques that rely on self-report or 
chart review. Various evidence-based psychotherapy models, such as cognitive-
behavioral therapy for psychosis (37,38), multisystemic therapy (39), and adolescent 
substance abuse treatment (40), often assess treatment integrity at the clinical interaction 
level. Integrity at this level has been linked to positive outcomes for consumers (41). 
With the exception of some measures focused on practitioners’ general knowledge (42–
45), evidence-based psychiatric rehabilitation programs lack clinician-level instruments, 
particularly those addressing competence. Therefore, the goal of the project described in 
this report was to create a clinician-level competency scale for IMR and test its 
psychometric properties. 
 
Methods 
Creation of the scale 
Two groups of subject matter experts (group 1: ABM, LGS, and MPS; group 2: KTM 
and MS) each independently created clinician-level IMR competence scales based on the 
IMR Fidelity Scale (33) and on two unpublished instruments used to evaluate provider 
competence: the Minnesota IMR Clinical Competence Scale and the IMR Knowledge 
Test. The scale creators included an IMR model creator, three researchers with extensive 
experience in IMR implementation, and an experienced IMR clinical supervisor. The 
scale was developed to rate either live or audio-recorded sessions. The draft scales from 
the two groups included 15 and 24 items, respectively. The content of these items 
overlapped; however, one group included an item on recovery orientation (retained in the 
final version) and items pertinent to specific IMR modules (eliminated from the final 
version). Items were compared and reconciled.  
 
We initially set out to create behaviorally specific anchors using a 5-point scale, to be 
consistent with the IMR Fidelity Scale. For five items we were able to create anchors 
with good agreement between investigators. However, we had difficulty specifying 
anchors for 11 of the items, and we used a more generic set of anchors for those items 
that was based on the work of Blackburn and colleagues (46). Higher scores correspond 
to greater competence in administering the target IMR element. After the initial version 
was created, investigators independently rated recordings of IMR sessions and then 
compared and discussed ratings, rationale for ratings, and any discrepancies. 
Investigators revised the scale, anchors, and rating criteria on the basis of these 
discussions. This process was repeated until no major rating discrepancies existed and 
investigators agreed that no further changes were necessary. This process took 14 
iterations. The resulting IMR Treatment Integrity Scale (IT-IS) includes 13 required 
items and three optional items rated only when the particular skill is attempted. [The 
scale is available online as a data supplement to this article.]  
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Reliability testing 
Sampling. Group sessions were audiotaped as part of a randomized trial of IMR for adults 
with schizophrenia. Participants were randomly assigned to either weekly IMR or control 
groups. Participants included veterans at the local Department of Veterans Affairs 
medical center, as well as consumers at a local community mental health center, with 
groups held at the respective facilities. Inclusion criteria were a diagnosis of 
schizophrenia or schizoaffective disorder confirmed by the Structured Clinical Interview 
for DSM-IV (SCID) (47), passing scores on a simple cognitive screen (48), willingness to 
participate in a group intervention, and current enrollment in services at either 
participating facility. Participants were paid $20 for each completed interview, but they 
were not paid for group attendance.  
 
Group facilitators. IMR and control groups were facilitated initially by a licensed clinical 
social worker and later by a doctoral-level clinical psychologist (ABM), both of whom 
had previous experience providing and consulting on IMR. Groups were cofacilitated by 
clinical psychology graduate students (including LGS, AM, NR, CT, and LW) with a 
range of clinical experience. 
 
Procedures. IMR groups were conducted according to the group guidelines in the revised 
IMR implementation toolkit (49). A typical group included brief socialization, discussion 
of items for the agenda, review of previously covered material, presentation of new 
material (guided by educational handouts from the IMR workbook and taught using 
motivation-based, educational, and cognitive-behavioral techniques), and goal setting and 
follow-up. The control group consisted of unstructured support, in which group members 
chose discussion topics and facilitators encouraged participation and maintained basic 
group ground rules (for example, mutual respect and confidentiality). Facilitators were 
instructed not to use educational materials or IMR-related teaching techniques, such as 
cognitive-behavioral techniques, but rather to use supportive therapeutic techniques (for 
example, active listening). 
 
For rating we randomly selected 60 IMR sessions and 20 control group sessions (without 
replacement, separate draws for IMR and control). Raters were four clinical psychology 
graduate students (AM, NR, CT, and LW) with experience providing IMR. Raters were 
trained by the scale creators; scale creators did not serve as raters. Each rater scored 30 
IMR tapes and ten control group tapes, and each session was rated by two raters (each 
rater overlapped with every other rater on an equal number of sessions). Both raters 
independently scored each session and then discussed any discrepancies and reached a 
consensus rating.  
 
This study was conducted between May 2009 and May 2011 and was approved by the 
Indiana University–Purdue University Indianapolis Institutional Review Board. 
 
Analyses. First we examined interrater reliability for the total IT-IS and individual items 
by computing intraclass correlation coefficients (ICCs); sessions in which a rater was also 
a group cofacilitator (18 sessions, or 23%) were excluded from this analysis. Systematic 
rater bias was assessed by comparing mean ratings of total scores across raters by using 
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analyses of variance. The remainder of the analyses were conducted with one of the two 
raters’ scores, randomly selected (except when one rater was a group cofacilitator, in 
which case the other rater’s scores were used).  
 
The second set of analyses examined the factor structure and internal consistency of the 
scale. We considered two potential factor structures—a one-factor structure and a two-
factor structure (general therapeutic elements and IMR-specific elements). We used 
confirmatory factor analyses to compare the relative fit of the two models (50,51) and 
selected the best model on the basis of goodness of fit and parsimony. Descriptive 
statistics were examined for range, distribution, and ceiling-floor effects for individual 
items. Internal consistency was examined through inspection of item-to-total correlations 
and Cronbach’s alpha. Given the meaningful difference between adherence (using 
prescribed elements) and competence (skill in using the elements), item analyses were 
repeated with just the IMR sessions (excluding the control sessions) to test the 
relationship between skill at specific IMR components within sessions.  
 
We also evaluated whether IMR competence was independent of when and where the 
session took place. To examine this, we correlated group date and IT-IS score and 
conducted an independent-samples t test comparing IT-IS scores by site. Finally, 
construct validity was examined through comparison of known groups. We hypothesized 
that IMR sessions would receive higher scores than control group sessions on the total 
scale and on the specific IMR subscales. We tested this hypothesis by using independent-
samples t tests and excluding sessions in which a rater was also the group leader (given 
leaders’ a priori knowledge of the group condition).  
 
Results 
As shown in Table 1, interrater reliability for the total scale score was excellent 
(ICC=.92, p<.001). Reliability for individual items was variable, with ICCs ranging from 
.03 (group member involvement) to .95 (IMR curriculum). Interrater reliability tended to 
be worse for general therapeutic items and items using the generic anchors. Interrater 
reliability did not vary substantially by rater pair (Table 2). Mean scores did not differ by 
rater: rater 1, 3.33±.82; rater 2, 3.38 ±.92; rater 3, 3.27 ±.77; rater 4, 3.41±.75). The 
remaining analyses were conducted using one of the two raters’ scores.  
 
Total and item means, standard deviations, and ranges are presented in Table 3. In regard 
to the confirmatory factor analysis, goodness-of-fit indicators were compared between 
the one-factor and two-factor models. Values were as follows for the one-factor model: 
{chiχ2}=167.78, df=64; standardized root mean square residual (RMSR)=.08; adjusted 
goodness-of-fit index (GFI)=.71; root mean square error of approximation 
(RMSEA)=.13; and Bentler comparative fit index=.88. For the two-factor model, these 
values were as follows: {chiχ2}=244.03, df=63; standardized RMSR=.26; adjusted 
GFI=.67; RMSEA=.17; and Bentler comparative fit index=.78. Overall, results indicate 
that the one-factor model fit is a good fit and better than the two-factor model.  
 
Regarding internal consistency, the items specific to group processes (group member 
involvement and enlisting mutual support) were not calculated for 18 sessions (23%) 
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because those sessions were attended by only one participant. Therefore, alphas and item-
to-total correlations were calculated for the 62 sessions for which all items could be 
calculated. Overall internal consistency was high both including and excluding the group 
items (Cronbach’s {α alpha}=.90 and .91, respectively). As shown in Table 1, item-to-
total correlations ranged from very poor (enlisting mutual support, r=–.07) to very strong 
(structure and efficient use of time, r=.91). Alphas did not increase more than .02 with the 
removal of any item. When only the IMR session tapes were used, the overall internal 
consistency was weaker but still in the acceptable range ({α alpha}=.79). Individual items 
varied in item-to-total correlations; enlisting mutual support was negatively related to the 
total score. 
 
As hypothesized, total IT-IS scores were significantly higher for IMR sessions than for 
control group sessions (Table 3), supporting the construct validity of the scale. Means for 
items were higher for IMR sessions than for control sessions, with the exception of 
enlisting mutual support. The scores for the VA sessions (N=44, mean score=3.35±.86) 
did not differ from those for the sessions conducted at the community site (N=36, mean 
score=3.36±.81). The mean IT-IS score was also not related to date of the group session. 
 
Discussion 
This study provided promising preliminary results on the reliability and validity of the 
IT-IS, a newly developed measure of IMR clinician competence. The total scale had 
excellent interrater reliability and adequate item-level interrater reliability, despite some 
notable exceptions. The scale was internally consistent and best fit a one-factor model. 
As hypothesized, scores on the IT-IS did not systematically differ by treatment site, rater, 
or date of the session.  
 
Two items are candidates for removal from the IT-IS. The item about enlisting mutual 
support did not distinguish IMR sessions from control group sessions and was negatively 
related to overall competence within IMR sessions. Conversely, therapeutic relationship 
did differ between the IMR and control groups, although it theoretically should not. 
Interrater reliability was also poor for this item, and it was only weakly related to the total 
score in the total sample. There was also a ceiling effect (mean=4.5) in the sample, which 
could account for the low reliability and minimal relationship to total score. Therapeutic 
alliance is an important common factor in psychotherapy and has been found to moderate 
the link between treatment integrity and treatment outcomes in other research (52,53). It 
is possible that wider variability of this item would be found if a larger number of group 
leaders were sampled. The scoring criteria for this item could also be revised to make it 
less lenient. Another alternative would be to supplement the IT-IS with other validated 
measures of common therapeutic factors (for example, the Working Alliance Inventory 
[54]). 
 
The construct validity of the scale was supported: IMR sessions were rated higher than 
control group sessions on the total IT-IS and on all but one IT-IS item. Structure and 
efficient use of time was most strongly related to total score and may be most indicative 
of an IMR session compared with an unstructured intervention group. However, this 
relationship may be less predictive of IMR when compared with other structured 
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interventions, such as cognitive-behavioral therapy or cognitive-processing therapy. 
Future work is needed to examine how the scale performs when IMR is compared with 
other structured interventions. Within the IMR sample, action planning was most strongly 
associated with the total score and therefore may be most indicative of quality within 
IMR. In our clinical experience with IMR, assisting consumers to convert abstract 
recovery goals into tangible steps may be emblematic of IMR. 
 
Implications 
The IT-IS has several potential important uses. Clinically, the IT-IS can serve as a 
valuable training tool by specifying the critical elements of IMR and the behaviors 
associated with competent practice. In addition, the IT-IS can be used by supervisors as a 
tool to provide specific feedback and develop performance improvement goals (55). 
From a programmatic standpoint, the IT-IS provides an indicator of variability between 
clinicians and could be used to assess and plan for additional training needs (56).  
 
In research applications, previous studies have used the IMR Fidelity Scale to monitor 
overall program fidelity. However, there may be significant variability in the quality of 
IMR implementation between practitioners within the same program. By monitoring 
competence at the level of clinical interactions, researchers can obtain a more fine-
grained evaluation of the IMR process. An important next step will be examining the 
relationship between competence (IT-IS items), IMR mechanism of action, and 
outcomes.  
 
Monitoring with both the IMR Fidelity Scale and the IT-IS would ensure faithful 
implementation and provide accountability for funding, regulatory bodies, and other 
stakeholders. The IT-IS complements and extends the IMR Fidelity Scale by assessing 
individual clinicians. However, there are some structural elements on the IMR Fidelity 
Scale that are not captured by the IT-IS (for example, group size, session length, and 
comprehensive curriculum) that would still be important to assess at the program level. 
We view the two scales as complementary, rather than competing, tools. 
 
Limitations 
This study had several limitations. The study used a fairly homogeneous sample of 
sessions, and the group sessions were cofacilitated by creators of the IT-IS or IT-IS raters 
(although only sessions rated by two raters who were not cofacilitators in the session 
were included in interrater reliability analyses). Although session recordings were 
blinded to the treatment condition and date of the recording, the raters’ knowledge of the 
study and other treatment providers made true blinding impossible. Future studies should 
use raters who play no role in the intervention. In a related issue, the highly structured 
and technically specific nature of IMR makes it highly distinguishable from an 
unstructured control group. Future studies should use the IT-IS to compare IMR to other 
structured, but distinct, interventions, such as cognitive-behavioral training or social 
skills training, to provide a more rigorous test of known-groups validity. The IT-IS 
should also be evaluated in individual IMR sessions to ensure applicability across 
modalities. Finally, the IT-IS included three optional items that are rated only when the 
specific element is used. In the study sample, application of these elements was not 
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sufficient to permit analysis of these items. Future studies should intentionally sample for 
sessions in which these elements could be rated.  
 
Conclusions 
The IT-IS is a promising measure of the competence of IMR practitioners. A revised 
version of the scale could be valuable in a variety of contexts including clinical, 
supervisory, administrative, and research. Future studies are needed to replicate this study 
with independent raters and to extend the research to nongroup IMR.  
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